{
    "clinical_study": {
        "@rank": "56825", 
        "acronym": "VELOCITY", 
        "arm_group": [
            {
                "arm_group_label": "Therapeutic Hypothermia Treatment", 
                "arm_group_type": "Experimental"
            }, 
            {
                "arm_group_label": "No Hypothermia Treatment", 
                "arm_group_type": "Active Comparator", 
                "description": "control group is no hypothermia treatment"
            }
        ], 
        "brief_summary": {
            "textblock": "This study will look at the safety of treating patients with heart attack with mild\n      hypothermia induced using a system of automated peritoneal lavage.  The hypothesis is that\n      the Velomedix Automated Peritoneal Lavage System can treat patients with heart attack safely\n      and with adequate performance."
        }, 
        "brief_title": "Evaluation of Ultrafast Hypothermia Before Reperfusion in STEMI Patients", 
        "completion_date": {
            "#text": "September 2014", 
            "@type": "Anticipated"
        }, 
        "condition": [
            "ST-elevation MI", 
            "Hypothermia"
        ], 
        "condition_browse": {
            "mesh_term": [
                "Hypothermia", 
                "Myocardial Infarction"
            ]
        }, 
        "detailed_description": {
            "textblock": "The study aims to determine the safety and feasibility of using the Velomedix Automated\n      Peritoneal Lavage System to treat patients with STEMI using therapeutic hypothermia.\n      Patients will undergo cooling, maintenance and rewarming and applicable data will be\n      gathered on device performance and patient safety.  Patient temperature and vital signs will\n      be monitored in addition to various laboratory values.  Adverse event reporting will take\n      place at multiple time intervals and follow-up will continue out to 6-months."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Clinical symptoms consistent with acute STEMI lasting at least 30 minutes\n\n          -  STEMI with ST-Elevation of \u22652 mm in two or more contiguous ECG leads\n\n          -  Patient eligible for PCI\n\n        Exclusion Criteria:\n\n          -  Cardiac arrest with return of spontaneous circulation\n\n          -  Known prior history of MI\n\n          -  Known history of severe COPD requiring supplemental home oxygen\n\n          -  Patient experiencing intractable cardiogenic shock, or requiring immediate placement\n             of a mechanical cardiac assist device\n\n          -  Known severe anemia or abnormal platelet count\n\n          -  Known significant renal insufficiency\n\n          -  Known contraindication for MRI\n\n          -  Known contraindications to hypothermia, such as temperature-sensitive hematological\n             dyscrasias or vasospastic disorders"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "85 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "60", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "July 30, 2012", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01655433", 
            "org_study_id": "VMXP-2490"
        }, 
        "intervention": [
            {
                "arm_group_label": "Therapeutic Hypothermia Treatment", 
                "description": "Velomedix, Automated Peritoneal Lavage System", 
                "intervention_name": "Velomedix APLS device", 
                "intervention_type": "Device"
            }, 
            {
                "arm_group_label": "No Hypothermia Treatment", 
                "intervention_name": "No Hypothermia Treatment", 
                "intervention_type": "Other"
            }
        ], 
        "is_fda_regulated": "Yes", 
        "is_section_801": "Yes", 
        "keyword": [
            "ST-elevation MI", 
            "Hypothermia"
        ], 
        "lastchanged_date": "February 20, 2014", 
        "location": [
            {
                "facility": {
                    "address": {
                        "city": "Huntsville", 
                        "country": "United States", 
                        "state": "Alabama", 
                        "zip": "35801"
                    }, 
                    "name": "Heart Center Research, LLC"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Los Angeles", 
                        "country": "United States", 
                        "state": "California"
                    }, 
                    "name": "LA County USC Hospital"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Gainesville", 
                        "country": "United States", 
                        "state": "Georgia", 
                        "zip": "30501"
                    }, 
                    "name": "Northeast Georgia Medical Center"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "New Orleans", 
                        "country": "United States", 
                        "state": "Louisiana"
                    }, 
                    "name": "Ochsner Medical Center"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Nashville", 
                        "country": "United States", 
                        "state": "Tennessee"
                    }, 
                    "name": "Vanderbilt University"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Victoria", 
                        "country": "Canada", 
                        "state": "British Columbia", 
                        "zip": "VSR 4R2,"
                    }, 
                    "name": "Victoria Heart Institute Foundation"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Quebec City", 
                        "country": "Canada", 
                        "state": "Quebec", 
                        "zip": "G1V 4G5"
                    }, 
                    "name": "Institut Universitaire de cardiologie et pneumologie de Qu\u00e9bec (Hopital Laval)"
                }
            }
        ], 
        "location_countries": {
            "country": [
                "United States", 
                "Canada"
            ]
        }, 
        "number_of_arms": "2", 
        "official_title": "VELOCITY: Pilot Study to Evaluate Ultrafast Hypothermia Before Reperfusion in Patients With Acute ST-Elevation Myocardial Infarction", 
        "overall_official": [
            {
                "affiliation": "New York Presbyterian Hospital / Columbia University Medical Center", 
                "last_name": "Gregg Stone, MD", 
                "role": "Principal Investigator"
            }, 
            {
                "affiliation": "University of Washington, Harberview Center", 
                "last_name": "Graham Nichol, MD", 
                "role": "Principal Investigator"
            }
        ], 
        "overall_status": "Active, not recruiting", 
        "oversight_info": {
            "authority": "United States: Food and Drug Administration", 
            "has_dmc": "Yes"
        }, 
        "phase": "Phase 2", 
        "primary_completion_date": {
            "#text": "April 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "Composite of new-onset serious adverse events, specifically death, ischemia driven target vessel revascularization (TVR), recurrent MI, pneumonia, sepsis, ventricular tachycardia or fibrillation requiring cardioversion, renal failure, peritonitis and significant bleeding.", 
            "measure": "Composite of new-onset SAEs", 
            "safety_issue": "Yes", 
            "time_frame": "30 days"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01655433"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "description": "MACE (cardiac related mortality, recurrent MI, or ischemia driven target vessel revascularization (PCI or CABG) at 30 days", 
                "measure": "MACE rate", 
                "safety_issue": "Yes", 
                "time_frame": "30 days"
            }, 
            {
                "description": "All cause mortality through 6 months", 
                "measure": "All cause mortality", 
                "safety_issue": "Yes", 
                "time_frame": "6 months"
            }, 
            {
                "description": "Myocardial infarct size at 3 days post-procedure", 
                "measure": "Myocardial infarct size", 
                "safety_issue": "No", 
                "time_frame": "3 days"
            }
        ], 
        "source": "Velomedix, Inc.", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Velomedix, Inc.", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "November 2012", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Safety Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "February 2014"
    }
}